CIK 0001661998 · Non-accelerated filer<br>Smaller reporting company
Q32 Bio Inc.
Sign in to watch- Ticker
- QTTB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 473468154
- Phone
- 781-999-0232
- Business address
- 830 WINTER STREET, WALTHAM, MA, 02451
- Former names
- Q32 Bio Inc., Homology Medicines, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $320,396
- in 6 filings
Net −$320,396. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-06 | Morrison Jodie Pope CEO | Sale | −3,221 | $8.32 | $27K | 340,038 |
| 2026-10-06 | Violette Shelia M. Chief Scientific Officer | Sale | −917 | $8.32 | $8K | 126,854 |
| 2026-10-06 | Kalowski Lee CFO and President | Sale | −1,301 | $8.32 | $11K | 137,170 |
| 2026-08-25 | Kalowski Lee CFO and President | Sale | −3,972 | $16.56 | $66K | 138,471 |
| 2026-08-25 | Morrison Jodie Pope CEO | Sale | −9,845 | $16.56 | $163K | 343,259 |
| 2026-08-25 | Violette Shelia M. Chief Scientific Officer | Sale | −2,798 | $16.56 | $46K | 127,771 |
| 2026-07-16 | Violette Shelia M. Chief Scientific Officer | Grant or award | +37,500 | 130,569 | ||
| 2026-07-16 | Morrison Jodie Pope CEO | Grant or award | +132,000 | 353,104 | ||
| 2026-07-16 | Kalowski Lee CFO and President | Grant or award | +53,250 | 142,443 | ||
| 2026-06-30 | Manke Isaac Director | Option exercise | +53,521 | $2.80 | $150K | 53,521 |
| 2026-06-30 | Manke Isaac Director | Option exercise · Stock Option (Right to Buy) | −53,521 | 0 | ||
| 2026-06-12 | TZIANABOS ARTHUR Director | Grant or award · Stock Option (Right to Buy) | +10,826 | 10,826 | ||
| 2026-06-12 | Lundberg Sven Ante Director | Grant or award · Stock Option (Right to Buy) | +10,826 | 10,826 | ||
| 2026-06-12 | LAPORTE KATHLEEN Director | Grant or award · Stock Option (Right to Buy) | +10,826 | 10,826 | ||
| 2026-06-12 | Iwicki Mark T Director | Grant or award · Stock Option (Right to Buy) | +10,826 | 10,826 | ||
| 2026-06-12 | Xu Diyong Director | Grant or award · Stock Option (Right to Buy) | +10,826 | 10,826 | ||
| 2026-06-12 | Manke Isaac Director | Grant or award · Stock Option (Right to Buy) | +10,826 | 10,826 | ||
| 2026-06-12 | GRAYZEL DAVID S. Director | Grant or award · Stock Option (Right to Buy) | +10,826 | 10,826 | ||
| 2026-06-12 | Thistle Mary Director | Grant or award · Stock Option (Right to Buy) | +10,826 | 10,826 | ||
| 2026-06-12 | LAPORTE KATHLEEN Director | Grant or award · Stock Option (Right to Buy) | +9,810 | 9,810 |
Page 1 of 11 · 207 trades